spot_img
Saturday, August 13, 2022
More
    HomeHealthStartup will target cystic fibrosis with a new twist on gene therapy

    Startup will target cystic fibrosis with a new twist on gene therapy

    -



    Gene remedy builders depend on hollowed-out viruses to shuttle DNA into the physique, the place it might deal with or doubtlessly even remedy a genetic illness. However many of the dozens of corporations within the discipline use simply two sorts of viruses for his or her DNA supply. Carbon Biosciences hopes to broaden that toolbox.

    The Lexington, Mass., startup launched Tuesday with $38 million in collection A financing to create a brand new class of gene therapies primarily based on parvoviruses — a big household of viruses greatest identified for infecting canines, however comprised of many little-studied viruses that may infect people and different animals, too.

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,435FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts